EBS Financial Facts

Net income (loss) attributable to Emergent BioSolutions Inc.: -20.24M
Contracts and grants: 15.39M
See Full Income Statement

Total Emergent BioSolutions Inc. stockholders' equity: 477.5M
Goodwill: 47.19M
See Full Balance Sheet

Emergent BioSolutions, Inc. (EBS) Earnings

  |   Expand Research on EBS
Next EPS Date 8/5/14 *Est. EPS Growth Rate -175.0% *Last Qtr.
Average EPS % Beat Rate -40.5% Revenue Growth Rate +25.1% *Last Qtr.
Average % Move 1-Wk after EPS +1.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/8/12 Q411 $0.78$0.72 +$0.06$107.95M$109.32M = Details
3/10/11 Q410 $0.78$0.67 +$0.11$103.2M$102.03M = Details
3/7/13 Q412 $0.44$0.45 -$0.01$94.6M$95.09M = Details
3/6/14 Q413 $0.42$0.36 +$0.06$94.1M$93.83M = Details
8/4/11 Q211 $0.40$0.34 +$0.06$88.1M$84.2M = Details
11/7/13 Q313 $0.37$0.21 +$0.16$89.1M$79.13M = Details
8/2/12 Q212 $0.21$0.23 -$0.02$70.4M$76.2M = Details
8/5/13 Q213 $0.29$0.21 +$0.08$82.4M$75.73M = Details